Summit Securities Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,047
Closed -$238K 1086
2025
Q3
$238K Buy
+9,047
New +$233K 0.05% 251
2025
Q2
Sell
-15,919
Closed -$396K 1189
2025
Q1
$396K Buy
+15,919
New +$379K 0.06% 125
2023
Q1
Sell
-1,728
Closed -$28K 980
2022
Q4
$28K Buy
+1,728
New +$25.6K ﹤0.01% 836

Other funds holding FMS

Summit Securities Group's FMS Position: Q4 2025 in Review

Summit Securities Group sold out of Fresenius Medical Care (FMS) in Q4 2025, closing a stake of 9,047 shares — an estimated $238K sold.

Summit Securities Group first reported a position in FMS in Q4 2022 and held it in 3 quarters. The position peaked at $396K in Q1 2025. 214 funds tracked by Wall St. Rank hold FMS as of Q4 2025.

  • Summit Securities Group reported no remaining Fresenius Medical Care position as of Q4 2025 after selling out during the quarter.
  • Summit Securities Group sold 9,047 Fresenius Medical Care shares in Q4 2025, an estimated $238K.
  • Summit Securities Group first reported a position in Fresenius Medical Care in Q4 2022 and held it in 3 quarters.
  • Summit Securities Group's Fresenius Medical Care position peaked at $396K in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2025.

Based on Summit Securities Group's 13F filing for Q4 2025, filed 17 Feb 2026.